BGI Genomics
Asim Iqbal is an experienced sales professional with a strong background in the biotechnology and healthcare sectors. Currently serving as a Sales Manager at BGI Genomics since September 2022, Iqbal previously held the position of National Sales Manager at Ayyan Molecular Products from November 2020 to August 2022. Earlier roles include Team Leader, Senior Sales Specialist, and Sales Specialist at Alliance Global Group (AGBL) from December 2012 to October 2020, as well as Medical Technologist positions at Al-Razi Healthcare and Chughtais Lahore Lab from February 2010 to November 2012 and February 2008 to May 2009, respectively. Iqbal holds a Master of Philosophy (MPhil) in Molecular Biology from the University of Veterinary and Animal Sciences (2013-2015) and a Master’s degree in Molecular Biology from The University of Lahore (2010-2012).
This person is not in any offices
BGI Genomics
3 followers
BGI was founded in 1999 as a research organization to support the Human Genome Project. Over the years, BGI’s in-house research has contributed to the development of the field of Genomics in significant ways, as evidenced by a wealth of peer-reviewed publications in prestigious scientific journals. Today, BGI is actively participating in the fields of Cancer Research, Bio-sustainability and Personalized Medicine through a global network of collaborators. BGI Genomics is the world’s leading provider of genomic and proteomic services, now serving customers in more than 66 countries. We provide academic institutions, pharmaceutical companies, health care providers and other organizations with integrated genomic and proteomic services and solutions across a broad range of applications spanning basic and translational research, drug discovery, agriculture and health care. To provide these services, we operate a large network of service Laboratories in China, Hong Kong, the US and Europe. Our customers benefit from the highest level of sequencing experience in the world to support their research and drug discovery projects. Our service laboratories operate under strict internationally recognized quality systems, such as those from CAP and ISO. More recently, BGI developed and launched its own DNBseq™ sequencing technology, based on DNA Nanoball sequencing technology that was invented in our Complete Genomics research facility in Silicon Valley, California. Scientists around the world now rely on DNBseq NGS services for the highest quality data at the lowest cost.